Cannabis

The Valens Company and Verse Cannabis Roll Out Vape Cartridges, CBD Oil, and Hydrocarbon-Derived Crumble in Various Provinces

Thursday, August 13, 2020 - 10:00pm

Additionally, the Verse Originals 1:20 CBD oil is expected to be available soon in Alberta, British Columbia and Ontario.

Key Points: 
  • Additionally, the Verse Originals 1:20 CBD oil is expected to be available soon in Alberta, British Columbia and Ontario.
  • Created using high quality extracts, the premium cannabis-derived CBD formula offers a subtle terpene profile with a citrus aroma.
  • In partnership with Verse, The Valens Company will also produce and manufacture additional products for the Verse Originals product line, including drink drops, using SRSE by Valens emulsion technology.
  • Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.

IntelGenx Reports Second Quarter 2020 Financial Results

Thursday, August 13, 2020 - 9:02pm

SAINT LAURENT, Quebec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter endedJune 30, 2020.

Key Points: 
  • SAINT LAURENT, Quebec, Aug. 13, 2020 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp.(TSX V:IGX)(OTCQB:IGXT) (the "Company" or "IntelGenx") today reported financial results for the second quarter endedJune 30, 2020.
  • 2020 Second Quarter Financial Summary:
    Cash and short-term investments totaled$3.1 millionas atJune 30, 2020
    Received its cannabis micro-processing license from Health Canada for its Montreal facility, in accordance with the Cannabis Act and Cannabis Regulations.
  • Operating costs and expenses were$1.8 millionfor the second quarter of 2020, versus$2.5 millionfor the corresponding three-month period of 2019.
  • IntelGenxwill host a conference call to discuss these 2020 second quarter financial results today,Thursday, August 13, 2020, at4:30 p.m. EDT.

Advisory - Accidental ingestion of edible cannabis products causing serious harm to children

Thursday, August 13, 2020 - 3:00pm

Issue: Children are accidentally ingesting illegal edible cannabis products and are experiencing serious harm resulting in hospitalization.

Key Points: 
  • Issue: Children are accidentally ingesting illegal edible cannabis products and are experiencing serious harm resulting in hospitalization.
  • What to do: Store cannabis products, whether purchased or homemade,securely and out of reach of children and young persons.
  • OTTAWA, ON, Aug. 13, 2020 /CNW/ -Health Canada is aware of several cases of serious harm resulting in hospitalization after children have accidentally consumed illegal edible cannabis products.
  • If you purchase edible cannabis, remember that legal edible cannabis products are limited to a maximum of 10 mg THC per package.

True Terpenes' New Scientific Advisory Board Commences Research

Thursday, August 13, 2020 - 2:00pm

The SAB will provide True Terpenes with external scientific and medical insights, as well as feedback on product and intellectual property development.

Key Points: 
  • The SAB will provide True Terpenes with external scientific and medical insights, as well as feedback on product and intellectual property development.
  • Two scientific luminaries with impressive careers in cannabis research and small molecule development, Dr. Ethan Russo and Dr. Randall Murphy, are inaugural members of the board.
  • "True Terpenes believes terpenes have a high potential to positively impact the quality of human life," said Chris Campagna, CEO of True Terpenes.
  • True Terpenes, a fully owned subsidiary of True Companies, is the industry-leading producer of effects-based, GMP/ISO/FSSC-certified terpenes and terpenoids blends.

Leading Cannabis Testing Company CannaSafe Ranks No. 13 on the 2020 Inc. 5000 List

Thursday, August 13, 2020 - 2:00pm

VAN NUYS, Calif., Aug. 13, 2020 /PRNewswire/ -- CannaSafe, California's leading ISO accredited cannabis testing laboratory, announced today it was ranked #13 in its debut appearance on Inc. magazine's annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies.

Key Points: 
  • VAN NUYS, Calif., Aug. 13, 2020 /PRNewswire/ -- CannaSafe, California's leading ISO accredited cannabis testing laboratory, announced today it was ranked #13 in its debut appearance on Inc. magazine's annual Inc. 5000 list, the most prestigious ranking of the nation's fastest-growing private companies.
  • In addition to its massive 12,144% three-year revenue growth, CannaSafe has made impressive strides as a company.
  • However, the company galvanized its reputation as a leader in cannabis testing nationwide when it took on a public education role during the vape crisis of 2019.
  • Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States.

Legal Cannabis' Spread Around the Globe Highlights Shift in Opinion

Thursday, August 13, 2020 - 2:00pm

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.

Key Points: 
  • Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
  • This growing cognizance is expected to help propel the industry forward," said Abraham Villegas, Founder of The Medical Cannabis Community.
  • "As the benefits of CBD become more widely published and accepted, funding for research and development will increase as well."
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

Legal Cannabis' Spread Around the Globe Highlights Shift in Opinion

Thursday, August 13, 2020 - 2:00pm

Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.

Key Points: 
  • Overall, the legal cannabis market is permeating throughout the U.S. states and is helping to create a multi-billion-dollar industry.
  • This growing cognizance is expected to help propel the industry forward," said Abraham Villegas, Founder of The Medical Cannabis Community.
  • "As the benefits of CBD become more widely published and accepted, funding for research and development will increase as well."
  • You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions.

Cannabis Global Announces Positive Balance Sheet Recapitalization with Retirement of Convertible Debt

Thursday, August 13, 2020 - 1:23pm

LOS ANGELES, Aug. 13, 2020 /PRNewswire/ -- Cannabis Global, Inc. (OTC: CBGL) ("Cannabis Global" or the "Company"), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is pleased to announce the repayment and retirement of multiple convertible notes along with other positive restructuring of the Company's debt obligations.

Key Points: 
  • LOS ANGELES, Aug. 13, 2020 /PRNewswire/ -- Cannabis Global, Inc. (OTC: CBGL) ("Cannabis Global" or the "Company"), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, is pleased to announce the repayment and retirement of multiple convertible notes along with other positive restructuring of the Company's debt obligations.
  • The Company expects these debt payments and restructurings to have a significant positive impact on the Company's balance sheet for the fiscal year ending August 31, 2020, minimize shareholder dilution risk.
  • The paid convertible notes and the note designated for the upcoming payment add up to a principal amount of $241,500.
  • Mr. Tabatabaei continued, "We believe that our recent name-change to Cannabis Global, and the convertible debt restructuring, will have long-term positive impacts relative to our cost of capital and overall shareholder value.

CV Sciences, Inc. Experts Contribute to Journal of Dietary Supplements First Special Issue on Cannabinoids

Thursday, August 13, 2020 - 1:45pm

In this issue, CV Sciences team of physicians and scientists took the opportunity to contribute to the growing body of scientific evidence on hemp-derived CBD as a non-prescription product.

Key Points: 
  • In this issue, CV Sciences team of physicians and scientists took the opportunity to contribute to the growing body of scientific evidence on hemp-derived CBD as a non-prescription product.
  • The editorial outlines the intent of the Special Issue on Cannabinoids, which is to address key scientific questions related to benefits, safety, and composition of popular hemp-derived CBD products.
  • Dr. Osvaldo Marinotti, Ph.D., Senior Scientist, CV Sciences, and Miles Sarill, M.Sc., National Educator for CV Sciences, co-authored, Differentiating Full-Spectrum Hemp Extracts from CBD Isolates: Implications for Policy, Safety and Science .
  • We are proud to contribute our teams expertise to this important cannabinoid report in the Journal of Dietary Supplements.

Medical Marijuana, Inc. Subsidiary Kannaway® Announces July 2020 as Best Month in Company History for Japanese Division

Thursday, August 13, 2020 - 2:00pm

SAN DIEGO, CA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the Company), the first-ever publicly traded cannabis company in the United States that launched the worlds first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway had its best month ever in Company history inJuly 2020.

Key Points: 
  • SAN DIEGO, CA, Aug. 13, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Medical Marijuana, Inc. (OTC: MJNA) (the Company), the first-ever publicly traded cannabis company in the United States that launched the worlds first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway had its best month ever in Company history inJuly 2020.
  • Kannaway is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products.
  • Medical Marijuana, Inc.s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com .
  • Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act.